Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hugo Hyung Bok Yoo & Flávia Luiza Marin. (2022) Treating Inflammation Associated with Pulmonary Hypertension: An Overview of the Literature. International Journal of General Medicine 15, pages 1075-1083.
Read now
Read now
Articles from other publishers (57)
Cheng Zeng, Jing Liu, Xialei Zheng, Xinqun Hu & Yuhu He. (2023) Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension. Respiratory Research 24:1.
Crossref
Crossref
Allison E. Norlander, Masako Abney, Jacqueline-Yvonne Cephus, Caroline E. RoeJonathan M. IrishNicholas J. Shelburne, Dawn C. Newcomb, Anna R. Hemnes & R. Stokes PeeblesJr.Jr.. (2023)
Prostaglandin I
2
Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension
. American Journal of Respiratory and Critical Care Medicine 208:6, pages 737-739.
Crossref
Crossref
Etienne-Marie Jutant, Mustapha K. Chelgham, Mina Ottaviani, Raphaël Thuillet, Benjamin Le Vely, Marc Humbert, Christophe Guignabert, Ly Tu & Alice Huertas. (2023) Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation.
Crossref
Crossref
Hui Hu, Jie Cai, Daoxi Qi, Boyu Li, Li Yu, Chen Wang, Akhilesh K. Bajpai, Xiaoqin Huang, Xiaokang Zhang, Lu Lu, Jinping Liu & Fang Zheng. (2023) Identification of Potential Biomarkers for Group I Pulmonary Hypertension Based on Machine Learning and Bioinformatics Analysis. International Journal of Molecular Sciences 24:9, pages 8050.
Crossref
Crossref
Giuditta Benincasa, Claudio Napoli, Joseph Loscalzo & Bradley A. Maron. (2023) Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension. American Heart Journal 258, pages 96-113.
Crossref
Crossref
Yujie Jiang, Yingfan Guo, Xuexiang Feng, Pingting Yang, Yi Liu, Xuejing Dai, Feilong Zhao, Dongyu Lei, Xiaohui Li, Yuan Liu & Ying Li. (2023) Iron metabolism disorder regulated by BMP signaling in hypoxic pulmonary hypertension. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1869:2, pages 166589.
Crossref
Crossref
Giuditta Benincasa, Bradley A. Maron, Ornella Affinito, Michele D’Alto, Monica Franzese, Paola Argiento, Concetta Schiano, Emanuele Romeo, Paola Bontempo, Paolo Golino, Liberato Berrino, Joseph Loscalzo & Claudio Napoli. (2022) Association Between Circulating CD4+ T Cell Methylation Signatures of Network-Oriented SOCS3 Gene and Hemodynamics in Patients Suffering Pulmonary Arterial Hypertension. Journal of Cardiovascular Translational Research 16:1, pages 17-30.
Crossref
Crossref
Min Yu, Xuecheng Wu, Liyao Peng, Mingxia Yang, Hong Zhou, Jian Xu, Jingjing Wang, Hong Wang, Weiping Xie & Hui Kong. (2022) Inhibition of Bruton’s Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Modulating Macrophage Polarization. Oxidative Medicine and Cellular Longevity 2022, pages 1-18.
Crossref
Crossref
Sandra Medrano-Garcia, Daniel Morales-Cano, Bianca Barreira, Alba Vera-Zambrano, Rahul Kumar, Djuro Kosanovic, Ralph Theo Schermuly, Brian B. Graham, Francisco Perez-Vizcaino, Alistair Mathie, Rajkumar Savai, Soni Pullamseti, Ghazwan Butrous, Edgar Fernández-Malavé & Angel Cogolludo. (2022) HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape. Cells 11:15, pages 2414.
Crossref
Crossref
Deping Kong & Ying Yu. (2022) Prostaglandin D2 signaling and cardiovascular homeostasis. Journal of Molecular and Cellular Cardiology 167, pages 97-105.
Crossref
Crossref
Ran-ran Wang, Tian-yi Yuan, Jian-mei Wang, Yu-cai Chen, Jiu-liang Zhao, Meng-tao Li, Lian-hua Fang & Guan-hua Du. (2022) Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective. Pharmacological Research 180, pages 106238.
Crossref
Crossref
Marta T. Gomes, Yang Bai, Simone R. Potje, Lu Zhang, Angelia D. Lockett & Roberto F. Machado. (2022) Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling. International Journal of Molecular Sciences 23:5, pages 2410.
Crossref
Crossref
Xiaomei Yang, Cheng Wang, Yicheng Lin & Peng Zhang. (2022) Identification of Crucial Hub Genes and Differential T Cell Infiltration in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Strategies. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Hua Guan, Xiaofeng Yang, Tao Shi, Yongjian Zhang, Aoqi Xiang & Yongxin Li. (2021) CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats. Cardiovascular Therapeutics 2021, pages 1-12.
Crossref
Crossref
Gema Mondéjar-Parreño, Angel Cogolludo & Francisco Perez-Vizcaino. (2021) Potassium (K+) channels in the pulmonary vasculature: Implications in pulmonary hypertension Physiological, pathophysiological and pharmacological regulation. Pharmacology & Therapeutics 225, pages 107835.
Crossref
Crossref
Tadeu L. Montagnoli, Jaqueline S. da Silva, Susumu Z. Sudo, Aimeé D. Santos, Gabriel F. Gomide, Mauro P. L. de Sá & Gisele Zapata-Sudo. (2021) ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension. Cells 10:7, pages 1648.
Crossref
Crossref
Julien Guihaire, Tobias DeuseDong WangJoshua M. SpinFrancis G. BlankenbergElie FadelHermann ReichenspurnerSonja Schrepfer. (2021) Immunomodulation Therapy Using Tolerogenic Macrophages in a Rodent Model of Pulmonary Hypertension. Stem Cells and Development 30:10, pages 515-525.
Crossref
Crossref
Xia Xu, Hua Feng, Chaochao Dai, Weida Lu, Jun Zhang, Xiaosun Guo, Qihui Yin, Jianli Wang, Xiaopei Cui & Fan Jiang. (2021) Therapeutic efficacy of the novel selective RNA polymerase I inhibitor CX‐5461 on pulmonary arterial hypertension and associated vascular remodelling. British Journal of Pharmacology 178:7, pages 1605-1619.
Crossref
Crossref
Valentina Mercurio, Alessandra Cuomo, Mario Naranjo & Paul M. Hassoun. 2011. Comprehensive Physiology. Comprehensive Physiology
1805
1829
.
Haihua Qiu, Yibo Zhang, Zhongyu Li, Ping Jiang, Shuhong Guo, Yi He & Yuan Guo. (2021) Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Haowei Zeng, Xiaoqin Liu & Yushun Zhang. (2021) Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Jing Xu, Yicheng Yang, Yuejin Yang & Changming Xiong. (2021) Identification of Potential Risk Genes and the Immune Landscape of Idiopathic Pulmonary Arterial Hypertension via Microarray Gene Expression Dataset Reanalysis. Genes 12:1, pages 125.
Crossref
Crossref
Jialing Wang, Hailong Li, Tian Xia, Jun Feng & Ru Zhou. (2021) Pulmonary arterial hypertension and flavonoids: A role in treatment. Chinese Journal of Physiology 64:3, pages 115.
Crossref
Crossref
Keshava Rajagopal, Andrew J. Bryant, Sandeep Sahay, Nancy Wareing, Yang Zhou, Lavannya M. Pandit & Harry Karmouty‐Quintana. (2020) Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra. British Journal of Pharmacology 178:1, pages 172-186.
Crossref
Crossref
Chao Tang, Yunmei Luo, Sha Li, Bo Huang, Shangfu Xu & Lisheng Li. (2021) Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats. Biomedicine & Pharmacotherapy 133, pages 111081.
Crossref
Crossref
Stefanie Krick. 2021. Fibroblast Growth Factor 23. Fibroblast Growth Factor 23
183
192
.
Timothy Klouda & Ke Yuan. 2021. Lung Inflammation in Health and Disease, Volume I. Lung Inflammation in Health and Disease, Volume I
351
372
.
Shuxin Liang, Ankit A. Desai, Stephen M. Black & Haiyang Tang. 2021. Lung Inflammation in Health and Disease, Volume I. Lung Inflammation in Health and Disease, Volume I
275
303
.
Marina ZemskovaNolan McClainMaki NiihoriMathews V. VargheseJoel JamesRuslan Rafikov & Olga Rafikova. (2020) Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex. Hypertension 76:6, pages 1787-1799.
Crossref
Crossref
Max-Paul Winter, Smriti Sharma, Johanna Altmann, Veronika Seidl, Adelheid Panzenböck, Arman Alimohammadi, Thomas Zelniker, Bassam Redwan, Felix Nagel, David Santer, Alexander Stieglbauer, Bruno Podesser, Maria Sibilia, Thomas Helbich, Gerald Prager, Aysegül Ilhan-Mutlu, Matthias Preusser & Irene M. Lang. (2020) Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension. Basic Research in Cardiology 115:6.
Crossref
Crossref
Tove Lekva, Lars Gullestad, Kaspar Broch, Pål Aukrust, Arne K. Andreassen & Thor Ueland. (2020) Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension. Scientific Reports 10:1.
Crossref
Crossref
Han Wang, Ruiling Qin & Yanqin Cheng. (2020) LncRNA-Ang362 Promotes Pulmonary Arterial Hypertension by Regulating miR-221 and miR-222. Shock 53:6, pages 723-729.
Crossref
Crossref
Rui Zhang, Yang-Yang He & Zhi-Cheng Jing. (2020) Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases. Frontiers in Pharmacology 11.
Crossref
Crossref
Yin Kang, Guangyan Zhang, Emma C. Huang, Jiapeng Huang, Jun Cai, Lu Cai, Sheng Wang & Bradley B. Keller. (2020) Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension. American Journal of Physiology-Heart and Circulatory Physiology 318:4, pages H853-H866.
Crossref
Crossref
James West, Xinping Chen, Ling Yan, Santhi Gladson, James Loyd, Hamid Rizwan & Megha Talati. (2020) Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension. Pulmonary Circulation 10:1, pages 1-11.
Crossref
Crossref
Haihua Qiu, Yi He, Fan Ouyang, Ping Jiang, Shuhong Guo & Yuan Guo. (2019) The Role of Regulatory T Cells in Pulmonary Arterial Hypertension. Journal of the American Heart Association 8:23.
Crossref
Crossref
Despοina Ntiloudi, Khaled Qanud, Jacquelyn-Nicole Tomaio, George Giannakoulas, Yousef Al-Abed & Stavros Zanos. (2019) Pulmonary arterial hypertension: the case for a bioelectronic treatment. Bioelectronic Medicine 5:1.
Crossref
Crossref
Jie Shu, Wei Liu, Fei Han & Fanyan Luo. (2019)
Trimethoxystilbene Reduces Nuclear Factor Kappa B, Interleukin-6, and Tumor Necrosis Factor-
α
Levels in Rats with Pulmonary Artery Hypertension
. BioMed Research International 2019, pages 1-8.
Crossref
Crossref
Guosen Yan, Jinxia Wang, Tao Yi, Junfen Cheng, Haixu Guo, Yuan He, Xiaorong Shui, Zeyong Wu, Shian Huang & Wei Lei. (2019) Baicalin prevents pulmonary arterial remodeling in vivo via the AKT/ERK/NF‐κB signaling pathways. Pulmonary Circulation 9:4, pages 1-10.
Crossref
Crossref
Larissa A. Shimoda. (2019) CA Dreamin’: Carbonic Anhydrase Inhibitors, Macrophages, and Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology 61:4, pages 412-413.
Crossref
Crossref
Ying Li, Li Yang, Liang Dong, Zhi-wei Yang, Jing Zhang, Sheng-li Zhang, Meng-jie Niu, Jing-wen Xia, Yi Gong, Ning Zhu, Xiu-juan Zhang, Yuan-yuan Zhang, Xiao-min Wei, You-zhi Zhang, Peng Zhang & Sheng-qing Li. (2019) Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs. Acta Pharmacologica Sinica 40:10, pages 1322-1333.
Crossref
Crossref
Kondababu Kurakula, Xiao-Qing Sun, Chris Happé, Denielli da Silva Goncalves Bos, Robert Szulcek, Ingrid Schalij, Karien C. Wiesmeijer, Kirsten Lodder, Ly Tu, Christophe Guignabert, Carlie J.M. de Vries, Frances S. de Man, Anton Vonk Noordegraaf, Peter ten Dijke, Marie-José Goumans & Harm Jan Bogaard. (2019) Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling. European Respiratory Journal 54:3, pages 1802400.
Crossref
Crossref
Lei Wang, Jie Liu, Wang Wang, Xianmei Qi, Ying Wang, Bo Tian, Huaping Dai, Jing Wang, Wen Ning, Ting Yang & Chen Wang. (2019) Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of β-catenin. Thorax 74:6, pages 564-578.
Crossref
Crossref
Wei Zhuang, Guili Lian, Bangbang Huang, Apang Du, Jin Gong, Genfa Xiao, Changsheng Xu, Huajun Wang & Liangdi Xie. (2018) CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension. Molecular and Cellular Biochemistry 455:1-2, pages 169-183.
Crossref
Crossref
Yan Deng, Sheng-Lan Guo, Bin Wei, Xing-Cui Gao, Ying-Chuan Zhou & Jia-Quan Li. (2019) Activation of Nicotinic Acetylcholine α7 Receptor Attenuates Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Downregulating the NLRP3 Inflammasome. Frontiers in Pharmacology 10.
Crossref
Crossref
Shaolei Ma, Xian Wang, Jing Yao, Quan Cao & Xiangrong Zuo. (2018) Roles of apoptosis and inflammation in a rat model of acute lung injury induced right ventricular dysfunction. Biomedicine & Pharmacotherapy 108, pages 1105-1114.
Crossref
Crossref
Rana GhaliRaffaele Altara, William E. LouchAlessandro CataliottiZiad MallatAbdullah KaplanFouad A. ZoueinGeorge W. Booz. (2018) IL-33 (Interleukin 33)/sST2 Axis in Hypertension and Heart Failure. Hypertension 72:4, pages 818-828.
Crossref
Crossref
Laurence Dewachter & Céline Dewachter. (2018) Inflammation in Right Ventricular Failure: Does It Matter?. Frontiers in Physiology 9.
Crossref
Crossref
Guilin Chen, Shengkai Zuo, Juan Tang, Caojian Zuo, Daile Jia, Qian Liu, Guizhu Liu, Qian Zhu, Yuanyang Wang, Jian Zhang, Yujun Shen, Dongrui Chen, Ping Yuan, Zhiqiang Qin, Chengchao Ruan, Jue Ye, Xiao-Jian Wang, Yuping Zhou, Pingjin Gao, Peng Zhang, Jinming Liu, Zhi-Cheng Jing, Ankang Lu & Ying Yu. (2018) Inhibition of CRTH2-mediated Th2 activation attenuates pulmonary hypertension in mice. Journal of Experimental Medicine 215:8, pages 2175-2195.
Crossref
Crossref
Bing Liu, Rong Chang, Zhili Duan, Xiaofei Zhang, Yusong Shen, Xiangbo Liu, Jinchun Wu, Yajun Tuo & Junming Luo. (2018) The level of ROCK1 and ROCK2 in patients with pulmonary hypertension in plateau area. Scientific Reports 8:1.
Crossref
Crossref
Leigh M. Marsh, Katharina Jandl, Gabriele Grünig, Vasile Foris, Mina Bashir, Bahil Ghanim, Walter Klepetko, Horst Olschewski, Andrea Olschewski & Grazyna Kwapiszewska. (2018) The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension. European Respiratory Journal 51:1, pages 1701214.
Crossref
Crossref
Sabrina Ramelli & William T. Gerthoffer. 2018. The Epigenetics of Autoimmunity. The Epigenetics of Autoimmunity
273
295
.
Cheng Li, Pingping Liu, Rong Song, Yiqing Zhang, Si Lei & Shangjie Wu. (2017) Immune cells and autoantibodies in pulmonary arterial hypertension. Acta Biochimica et Biophysica Sinica 49:12, pages 1047-1057.
Crossref
Crossref
Xiao-Qing Sun, Antonio Abbate & Harm-Jan Bogaard. (2017) Role of cardiac inflammation in right ventricular failure. Cardiovascular Research 113:12, pages 1441-1452.
Crossref
Crossref
Alice Huertas, Ly Tu & Christophe Guignabert. (2017) New targets for pulmonary arterial hypertension. Current Opinion in Pulmonary Medicine 23:5, pages 377-385.
Crossref
Crossref
Huijuan Yuan & Pravin B. Sehgal. (2016) MxA Is a Novel Regulator of Endosome-Associated Transcriptional Signaling by Bone Morphogenetic Proteins 4 and 9 (BMP4 and BMP9). PLOS ONE 11:11, pages e0166382.
Crossref
Crossref
John C. Huetsch, Karthik Suresh, Meghan Bernier & Larissa A. Shimoda. (2016) Update on novel targets and potential treatment avenues in pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 311:5, pages L811-L831.
Crossref
Crossref